Drug Type Antibody fusion proteins |
Synonyms |
Target |
Mechanism Trop-2 inhibitors(Tumor-associated calcium signal transducer 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | KR | 23 Aug 2024 | |
Biliary Tract Neoplasms | Preclinical | KR | 09 Apr 2024 | |
Biliary Tract Neoplasms | Preclinical | KR | Genopharm Co. Ltd.Startup | 09 Apr 2024 |
Triple Negative Breast Cancer | Preclinical | KR | Genopharm Co. Ltd.Startup | 09 Apr 2024 |
Triple Negative Breast Cancer | Preclinical | KR | 09 Apr 2024 | |
Bladder Cancer | Preclinical | KR | 22 Mar 2024 |